195 related articles for article (PubMed ID: 25901726)
1. Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
Dong H; Zhang L; Qian Z; Zhu X; Zhu G; Chen Y; Xie X; Ye Q; Zang J; Ren Z; Ji Q
PLoS One; 2015; 10(4):e0123175. PubMed ID: 25901726
[TBL] [Abstract][Full Text] [Related]
2. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma.
Saigo K; Yoshida K; Ikeda R; Sakamoto Y; Murakami Y; Urashima T; Asano T; Kenmochi T; Inoue I
Hum Mutat; 2008 May; 29(5):703-8. PubMed ID: 18320596
[TBL] [Abstract][Full Text] [Related]
3. Distinct Patterns of HBV Integration and
Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Sung WK; Zheng H; Li S; Chen R; Liu X; Li Y; Lee NP; Lee WH; Ariyaratne PN; Tennakoon C; Mulawadi FH; Wong KF; Liu AM; Poon RT; Fan ST; Chan KL; Gong Z; Hu Y; Lin Z; Wang G; Zhang Q; Barber TD; Chou WC; Aggarwal A; Hao K; Zhou W; Zhang C; Hardwick J; Buser C; Xu J; Kan Z; Dai H; Mao M; Reinhard C; Wang J; Luk JM
Nat Genet; 2012 May; 44(7):765-9. PubMed ID: 22634754
[TBL] [Abstract][Full Text] [Related]
5. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
Jiang Z; Jhunjhunwala S; Liu J; Haverty PM; Kennemer MI; Guan Y; Lee W; Carnevali P; Stinson J; Johnson S; Diao J; Yeung S; Jubb A; Ye W; Wu TD; Kapadia SB; de Sauvage FJ; Gentleman RC; Stern HM; Seshagiri S; Pant KP; Modrusan Z; Ballinger DG; Zhang Z
Genome Res; 2012 Apr; 22(4):593-601. PubMed ID: 22267523
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
Mathkar PP; Chen X; Sulovari A; Li D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
[TBL] [Abstract][Full Text] [Related]
7. HIVID: an efficient method to detect HBV integration using low coverage sequencing.
Li W; Zeng X; Lee NP; Liu X; Chen S; Guo B; Yi S; Zhuang X; Chen F; Wang G; Poon RT; Fan ST; Mao M; Li Y; Li S; Wang J; Jianwang ; Xu X; Jiang H; Zhang X
Genomics; 2013 Oct; 102(4):338-44. PubMed ID: 23867110
[TBL] [Abstract][Full Text] [Related]
8. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
9. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma.
Li X; Zhang J; Yang Z; Kang J; Jiang S; Zhang T; Chen T; Li M; Lv Q; Chen X; McCrae MA; Zhuang H; Lu F
J Hepatol; 2014 May; 60(5):975-84. PubMed ID: 24362074
[TBL] [Abstract][Full Text] [Related]
10. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma.
Chiu YT; Wong JK; Choi SW; Sze KM; Ho DW; Chan LK; Lee JM; Man K; Cherny S; Yang WL; Wong CM; Sham PC; Ng IO
J Hepatol; 2016 Jun; 64(6):1256-64. PubMed ID: 26867494
[TBL] [Abstract][Full Text] [Related]
11. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
12. HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma.
He Z; Zhu J; Mo J; Zhao H; Chen Q
Mol Med Rep; 2020 Jul; 22(1):380-386. PubMed ID: 32319639
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
[TBL] [Abstract][Full Text] [Related]
14. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
Yan H; Yang Y; Zhang L; Tang G; Wang Y; Xue G; Zhou W; Sun S
Hepatology; 2015 Jun; 61(6):1821-31. PubMed ID: 25627239
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
18. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Zhao LH; Liu X; Yan HX; Li WY; Zeng X; Yang Y; Zhao J; Liu SP; Zhuang XH; Lin C; Qin CJ; Zhao Y; Pan ZY; Huang G; Liu H; Zhang J; Wang RY; Yang Y; Wen W; Lv GS; Zhang HL; Wu H; Huang S; Wang MD; Tang L; Cao HZ; Wang L; Lee TL; Jiang H; Tan YX; Yuan SX; Hou GJ; Tao QF; Xu QG; Zhang XQ; Wu MC; Xu X; Wang J; Yang HM; Zhou WP; Wang HY
Nat Commun; 2016 Oct; 7():12992. PubMed ID: 27703150
[TBL] [Abstract][Full Text] [Related]
19. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
20. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
